Home Cart 0 Sign in  
X

[ CAS No. 98400-69-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 98400-69-2
Chemical Structure| 98400-69-2
Chemical Structure| 98400-69-2
Structure of 98400-69-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 98400-69-2 ]

Related Doc. of [ 98400-69-2 ]

Alternatived Products of [ 98400-69-2 ]

Product Details of [ 98400-69-2 ]

CAS No. :98400-69-2 MDL No. :MFCD02179232
Formula : C10H14N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :DRZYCRFOGWMEES-UHFFFAOYSA-N
M.W : 194.23 Pubchem ID :9990210
Synonyms :

Safety of [ 98400-69-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280 UN#:N/A
Hazard Statements:H302-H317 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 98400-69-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 98400-69-2 ]
  • Downstream synthetic route of [ 98400-69-2 ]

[ 98400-69-2 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 98400-69-2 ]
  • [ 273-70-1 ]
Reference: [1] Heterocycles, 2004, vol. 63, # 7, p. 1555 - 1561
  • 2
  • [ 98400-69-2 ]
  • [ 42373-30-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 16, p. 3023 - 3025
  • 3
  • [ 98400-69-2 ]
  • [ 7397-68-4 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2003, vol. 40, # 4, p. 585 - 591
  • 4
  • [ 504-24-5 ]
  • [ 24424-99-5 ]
  • [ 98400-69-2 ]
YieldReaction ConditionsOperation in experiment
99% With dmap; triethylamine In tetrahydrofuran at 20℃; for 0.333333 h; Inert atmosphere 4-Aminopyridine (600 mg, 6.36 mmol), DMAP (600 μg, 5.00 μmol), Boc2O (1.57 mL, 7.00mmol) and Et3N (1 mL, 7.63 mmol) were suspended in anhydrous THF (3 mL) at rt, and stirredfor 20 min under argon atmosphere. After completion of the reaction, the reaction mixture was diluted with CH2Cl2 (5 mL) and washed with 0.1 N HCl (5 mL). The combined organic layers were dried over anhydrous MgSO4, filtered, and concentrated by rotary evaporation. Purification by column chromatography (30:1 CH2Cl2/MeOH) yielded S1w (1.30 g, >99percent) asa white solid.
95% With guanidine hydrochloride In ethanol at 35 - 40℃; for 0.25 h; General procedure: Amine (1 mmol) was added to a magnetically stirred solution of guanidine hydrochloride (15 molpercent) and di-tert-butyl dicarbonate (1.2 mmol) in EtOH (1 mL), at 35-40°C and stirred for appropriate time (Table 1). After completion of the reaction (followed by TLC or GC), EtOH was evaporated under vacuum and the residue either was washed with water to remove the catalyst or was dissolved in CH2Cl2 (or EtOAc) and filtered off to separate out the catalyst. Evaporation of the organic solvent (if used in work up) gives almost a pure product. In the cases of using an excess (Boc)2O the product was washed with petroleum ether or hexane to recover the residual (Boc)2O. If necessary, the product was further purified either by crystallization (hexane and dichloromethane, or diethyl ether and petroleum ether) or silica gel column chromatography using EtOAc-hexane (1: 6) as eluent.
94% at 20 - 25℃; for 3.6 h; Preparation of isatin derivatives To a well stirred solution of Boc anhydride (2.56 g, 11.7 mmol) in THF (10 mL) was added 4- aminopyridine (1.0 g, 10.6 mmol) in portions over 3 minutes while maintaining the temperature between 20°C and 25°C. No more exotherm was observed after 5 minutes. The reaction was then stirred at room temperature for 3.5 hours. After in vacuo concentration the crude mixture was then titurated in hexane (20 mL), filtered and washed with more hexane (~5 mL). The resulting solid dried under reduced pressure to yield 1.93 g (9.9 mmol, 94percent) of pyridin-4-yl-carbamic acid tert-butyl ester as a white solid and was used without further purification. LCMS (BDS-Hypersil C18,50 mm X 2.1 mm, 5 μ, 2.5 minutes) m/z 195 [MH]+ retension time 0.90 minutes, 100percent by UV at 215 nm.
94% at 100℃; for 0.0833333 h; Microwave irradiation; Green chemistry General procedure: Amine (1 mmol) and di-tert-butyl dicarbonate [(Boc)2O] (1.1 mmol) were placed in a microwave reaction vial. The LG microwave oven MG 555f was programmed to 300 W at 100 °C. The reaction was monitored using TLC. After the reaction, ice water was added to the reaction mixture which resulted in the precipitation of the product. The solid product was merely filtered off and washed with excess cold water. The product was pure enough for all practical purposes. For characterization purpose, it was further purified by column chromatography (Neutral Alumina as adsorbent, solvent system: Hexane: Ethyl acetate (7.5:2.5)).#10;
90% With triethylamine In dichloromethane at 0 - 20℃; for 3 h; To a stirred solution of pyridin-4-amine (A; 100 g, 1.06 mol) in CH2CI2 (1 L) under inert atmosphere were added triethylamine (161.47 g, 1.59 mol) and Boc-anhydride (255 g, 1.17 mol) at 0 °C. The reaction was warmed to RT and stirred for 3 h. After complete consumption of the starting material, the reaction mixture was diluted with water (400 mL) and the compound was extracted with CH2CI2 (2x500 mL). The combined organic extracts were washed with water (300 mL), dried over sodium sulfate, filtered and concentrated under reduced pressure to obtain the crude. The crude was purified through column chromatography eluting with 5percent MeOH/CH2Cl2 to afford BL (190 g, 90percent) as a white solid. *H NMR (500 MHz, DMSO- ): δ 9.80 (s, 1H), 8.33 (d, J = 5.5 Hz, 2H), 7.41 (d, J = 6.5 Hz, 2H), 1.48 (s, 9H).
88% With triethylamine In dichloromethane To a solution of 4-aminopyridine (50.0 g, 531 mmol) in triethylamine/CH2Cl2 (1:1, 200 mL) at 0°C was slowly added a solution of di-t-butyl-dicarbonate (116 g, 531 mmol) in CH2Cl2 (150 mL). The resulting mixture was allowed to warm to it overnight then was concentrated. The crude product was taken up in hot EtOAc, filtered and precipitated with hexanes. The precipitate was collected by filtration, washed with hexanes and dried under vacuum to give 91.0 g (88percent yield) of pure t-butyl carbamate.
84% at 20℃; for 1 h; 4-Aminopyridine (25 g, 265 mmol) was added slowly by a solid addition funnel to a stirred solution of di-t-butyl-di-carbonate (63.75 g, 292 mmol) in THF at room temperature. The solution was further stirred for 1 h at room temperature. The solvent was removed under reduced pressure and the residue was recrystalised by ether to yield 43.5 g (84 percent) of pyridine-4-yl-carbamic acid-tert-butyl ester (117) as white solid. MP: 260 °C ; 1H-NMR (DMSO-d6): d 1. 48 (s, 9H), 7.40 (dd, J = 1.2, 4.8 Hz, 1H), 8.33 (dd, J = 1. 2,4. 8 Hz, 1H), 9.93 (s, 1H) ; EIMS m/z 195 (M+1).
83% With triethylamine In DMF (N,N-dimethyl-formamide) To a stirring solution of 4-aminopyridine (15 g, 159 mmol) and triethylamine (24 mL, 175 mmol) in DMF (300mL) was addeddi-t-butyl dicarbonate (38 g, 175 mmol). After stirring overnight, the solvent was removed in vacuo. The residue was dissolved in ethyl acetate (500 mL); and the solution was washed with satd aq sodium bicarbonate, water and then brine. The organic phase was then dried withMgSO4, filtered and concentrated in vacuo to a volume of about 100 mL. The mixture was then sonicated and the precipitate was filtered and dried in vacuo to give 9.52 g (31percent) of the title compound. To the mother liquor was added about 50 g of silica gel and the mixture was concentrated in vacuo. The resulting dry pack was loaded onto a silica gel column prepared with a solution of 50percent ethyl acetate in hexanes and eluted with20percent ethyl acetate in dichloromethane, followed by a step gradient of50percent ethyl acetate in hexanes through ethyl acetate. The product containing fractions were combined and concentrated in vacuo to give another 16.16 g (52percent) of the title compound. 1NMR IS-MS, m/e 195.3(m+1)
83% at 20℃; for 0.5 h; A solution of di-tert-butyl dicarbonate (3.274g, 15 mmol) in CH2C12 (8 mL) was added to a solution of 4-aminopyridine (1.412g, 15 mmol) in CH2C12 (15 mL), and was stirred at room temperature for 30 minutes. Acidified with 1M HC1. Washed with CH2C12. Neutralized aqueous layer with K2C03. PARTITIONED between CH2C12 and water. The organic layer was washed with brine, dried (MGSO4), filtered, and concentrated under vacuum to provide 2. 41G (83percent) of PYRIDIN-4-YL-CARBAMIC acid tert-butyl ester.
70% With triethylamine In dichloromethane at 0 - 20℃; for 16 - 18 h; Di-tert-butyl dicarbonate (79.30 g, 0.36 mol) in dichloromethane (250 ml) was added dropwise over 45 min to a stirred suspension of 4-aminopyridine (27.05 g, 0.29 mol) and triethylamine (88 ml, 0.63 mol) in dichloromethane (250 ml) at 0 °C. The solution was stirred at room temperature for 18 h and then washed with water (2 x 250 ml). The organic layer was then dried and concentrated in vacuo to leave a residue which was slurried in ethyl acetate, filtered and dried in vacuo to give pyridin-4-yl-carbamic acid tert-butyl ester (39.62 g, 71 percent) as an off-white solid. No.H (400 MHz, CDC13) 8.44 (2H, dd J 6.4, 1. 6 Hz), 7.31 (2H, dd J 6.4, 1.6 Hz), 6.84 (1H, br s), 1.53 (9H, s) ; Tr = 0.90 min, m/z (ES+) (M+H)+ 195.18.
52% With triethylamine In dichloromethane; ethyl acetate; N,N-dimethyl-formamide A.
4-(Boc-amino)pyridine.
To a stirring solution of 4-aminopyridine (15 g, 159 mmol) and triethylamine (24 mL, 175 mmol) in DMF (300 mL) was added di-t-butyl dicarbonate (38 g, 175 mmol).
After stirring overnight, the solvent was removed in vacuo, the residue was dissolved in ethyl acetate (500 mL), and the solution was washed with satd aq sodium bicarbonate, water and then brine.
The organic phase was then dried with MgSO4, filtered and concentrated in vacuo to a volume of about 100 mL.
The mixture was then sonicated and the precipitate was filtered and dried in vacuo to give 9.52 g (31percent) of the title compound.
To the mother liquor was added about 50 g of silica gel and the mixture was concentrated in vacuo.
The resulting dry pack was loaded onto a silica gel column prepared with a solution of 50percent ethyl acetate in hexanes and eluted with 20percent ethyl acetate in dichloromethane, followed by a step gradient of 50percent ethyl acetate in hexanes through ethyl acetate.
The product containing fractions were combined and concentrated in vacuo to give another 16.16 g (52percent) of the title compound.
1H-NMR
IS-MS, m/e 195.3 (m+1)

Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 7, p. 1087 - 1091
[2] Organic and Biomolecular Chemistry, 2006, vol. 4, # 14, p. 2769 - 2771
[3] Chemistry Letters, 2010, vol. 39, # 11, p. 1127 - 1129
[4] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 9, p. 2114 - 2124
[5] Tetrahedron Letters, 2007, vol. 48, # 47, p. 8318 - 8322
[6] Journal of Organic Chemistry, 2011, vol. 76, # 17, p. 7132 - 7140
[7] Tetrahedron, 2001, vol. 57, # 43, p. 9033 - 9043
[8] Tetrahedron Letters, 1998, vol. 39, # 48, p. 8919 - 8922
[9] Synthesis, 2006, # 16, p. 2784 - 2788
[10] Tetrahedron Letters, 2011, vol. 52, # 12, p. 1260 - 1264
[11] Monatshefte fur Chemie, 2011, vol. 142, # 10, p. 1035 - 1043
[12] Patent: WO2005/97107, 2005, A2, . Location in patent: Page/Page column 36
[13] Tetrahedron Letters, 2012, vol. 53, # 43, p. 5803 - 5806
[14] Organic Letters, 2006, vol. 8, # 15, p. 3259 - 3262
[15] Patent: WO2014/117090, 2014, A1, . Location in patent: Page/Page column 123-124
[16] European Journal of Medicinal Chemistry, 2005, vol. 40, # 9, p. 908 - 917
[17] Patent: WO2007/61554, 2007, A2, . Location in patent: Page/Page column 12
[18] Journal of Organic Chemistry, 2004, vol. 69, # 20, p. 6772 - 6780
[19] Patent: WO2005/21546, 2005, A1, . Location in patent: Page/Page column 124; 207-208
[20] Patent: WO2005/49604, 2005, A2, . Location in patent: Page/Page column 105-106
[21] Patent: WO2004/76424, 2004, A1, . Location in patent: Page 266
[22] Patent: WO2005/113552, 2005, A1, . Location in patent: Page/Page column 20
[23] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2136 - 2145
[24] Patent: WO2005/121141, 2005, A1, . Location in patent: Page/Page column 13; 20
[25] Journal of Medicinal Chemistry, 2003, vol. 46, # 8, p. 1293 - 1305
[26] Chemical Communications, 2014, vol. 50, # 39, p. 5068 - 5071
[27] Tetrahedron Letters, 1994, vol. 35, # 48, p. 9003 - 9006
[28] Journal of Organic Chemistry, 1999, vol. 64, # 26, p. 9430 - 9443
[29] Patent: EP1577301, 2005, A1, . Location in patent: Page/Page column 70
[30] Patent: EP1270557, 2003, A1,
[31] Patent: EP1140905, 2003, B1,
[32] Patent: US2005/20645, 2005, A1,
[33] Patent: US2008/194547, 2008, A1, . Location in patent: Page/Page column 14
[34] Patent: EP1405852, 2004, A1, . Location in patent: Page 63
[35] Patent: EP1577302, 2005, A1, . Location in patent: Page/Page column 67
[36] Synthetic Communications, 2011, vol. 41, # 5, p. 715 - 719
[37] Patent: US2015/274720, 2015, A1, . Location in patent: Paragraph 0325
[38] Tetrahedron Letters, 2016, vol. 57, # 48, p. 5304 - 5307
[39] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 17, p. 4886 - 4897
  • 5
  • [ 504-24-5 ]
  • [ 24424-99-5 ]
  • [ 75-65-0 ]
  • [ 98400-69-2 ]
YieldReaction ConditionsOperation in experiment
99% With potassium hydroxide In water EXAMPLE 10
4-Anilinopyrido[4,3-d]pyrimidine
4-(N-t-Butoxycarbonylamino)pyridine.
To a mixture of 4-aminopyridine (2 g, 21.24 mmol), potassium hydroxide (3.57 g, 63.72 mmol), water (10 mL), and 2-methyl-2-propanol (4 mL) on ice is added di-t-butyl-dicarbonate (6.95 g, 31.87 mmol).
The resulting biphasic solution is stirred at 25° C. for 1 week, then water (20 mL) is added.
The solution is extracted with 1X CH2 Cl2 and 2X EtOAc.
The organic layer is dried (MgSO4) and concentrated under reduced pressure to give 4-(N-t-butoxycarbonylamino)pyridine (4.08 g, 99percent).
1 H NMR (DMSO) δ 9.84 (1H, s), 8.35 (2H, d, J=6 Hz), 7.44 (2H, d, J=7 Hz), 1.49 (9H, s).
Reference: [1] Patent: US5654307, 1997, A,
  • 6
  • [ 504-24-5 ]
  • [ 1538-75-6 ]
  • [ 98400-69-2 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 2012, vol. 51, # 8, p. 1168 - 1172,5
  • 7
  • [ 504-24-5 ]
  • [ 89985-91-1 ]
  • [ 98400-69-2 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1985, vol. 58, # 12, p. 3570 - 3575
  • 8
  • [ 504-24-5 ]
  • [ 98400-69-2 ]
Reference: [1] Patent: US6541505, 2003, B1,
  • 9
  • [ 55-22-1 ]
  • [ 98400-69-2 ]
Reference: [1] Tetrahedron Letters, 2016, vol. 57, # 48, p. 5304 - 5307
  • 10
  • [ 4427-22-9 ]
  • [ 98400-69-2 ]
Reference: [1] Tetrahedron Letters, 2016, vol. 57, # 48, p. 5304 - 5307
  • 11
  • [ 98400-69-2 ]
  • [ 68-12-2 ]
  • [ 116026-93-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2136 - 2145
[2] Journal of Medicinal Chemistry, 1999, vol. 42, # 16, p. 3023 - 3025
  • 12
  • [ 98400-69-2 ]
  • [ 116026-93-8 ]
Reference: [1] Patent: WO2006/59164, 2006, A2, . Location in patent: Page/Page column 37
  • 13
  • [ 98400-69-2 ]
  • [ 211029-67-3 ]
YieldReaction ConditionsOperation in experiment
54%
Stage #1: With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran; hexanes at -78 - -10℃; for 2.25 h;
Stage #2: With iodine In tetrahydrofuran; hexanes at -78℃; for 2.5 h;
n-Butyllithium (1.6 M in hexanes; 220 ml, 0.35 mol) was slowly dropwise over 30 min to a stirred solution of pyridin-4-yl-carbamic acid tert-butyl ester (26.08 g, 0.13 mol) and N,N,N,N-tetramethylethylenediamine (55 ml, 0.36 mol) in tetrahydrofuran (750 ml) at -78 °C. The solution was stirred at-78 °C for 15 min and 2 h at-10 °C. The mixture was cooled to -78 °C and a solution of iodine (95.11 g, 0.37 mol) in tetrahydrofuran (250 ml) was added dropwise over 30 min. The mixture was stirred for a further 2 h and then the mixture was quenched with water (250 ml) at 0 °C. A saturated solution of sodium sulfite (100 ml) was added and the organic layer separated. The aqueous layer was extracted with dichloromethane (2 x 500 ml) and then the combined organic extracts were dried and concentrated in vacuo to give a brown oil. Purification by flash column chromatography on silica gel eluting with 20 percent ethyl acetate : heptane gave (3-iodo-pyridin-4-yl)-carbamic acid tert-butyl ester (25.00 g, 58 percent) as an off-white solid, No.H (400 MHz, CDC13) 8.76 (1H, s), 8.35 (1H, d J 5.7 Hz), 8.11 (1H, d J 5.7 Hz), 7.04 (lH, br s), 1.55 (9H, s) ; Tr = 0.99 min, m/z (ES+) (M+H)+ 321.08.
Reference: [1] Patent: WO2005/121141, 2005, A1, . Location in patent: Page/Page column 13; 20
[2] Journal of Organic Chemistry, 2004, vol. 69, # 20, p. 6772 - 6780
  • 14
  • [ 110-18-9 ]
  • [ 98400-69-2 ]
  • [ 211029-67-3 ]
Reference: [1] Patent: US6541505, 2003, B1,
  • 15
  • [ 98400-69-2 ]
  • [ 197507-59-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 16, p. 3023 - 3025
  • 16
  • [ 124-38-9 ]
  • [ 98400-69-2 ]
  • [ 171178-34-0 ]
YieldReaction ConditionsOperation in experiment
35%
Stage #1: With n-butyllithium In tetrahydrofuran at -78 - 0℃; for 0.5 h; Inert atmosphere
Stage #2: at -78 - 20℃; for 2 h;
To a stirred solution of BL (12 g, 0.06 mol) in dry THF (200 mL) under inert atmosphere was added n-butyl lithium (79.12 mL, 0.18 mol) at -78 °C. The reaction was warmed to 0 °C and stirred for 30 min. Carbon dioxide gas was added to the reaction mass at -78 °C for 1 h, then at RT for 1 h. The reaction was monitored by TLC. After complete consumption of the starting material, the reaction mass was diluted with water (200 mL) and washed with diethyl ether (2x150 mL). The aqueous layer was acidified with citric acid to pH~4. The obtained solid was filtered and dried under vacuum to afford BM (5.1 g, 35percent) as a white solid. *H NMR (400 MHz, DMSO-i: δ 11.76 (br s, 1H), 8.96 (s, 1H), 8.52 (d, / = 15.0 Hz, 1H), 8.22 (d, / = 15.0 Hz, 1H), 1.49 (s, 9H).
30%
Stage #1: With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran at -40 - 20℃; for 0.333333 h;
Stage #2: at -78 - 20℃; for 3.25 h;
-Buli (1.6 M soln, 155 mL, 249 mmol) was added to a stirred solution of TMEDA (37.36 mL, 249 mmol) in THF AT-40 °C. The solution was allowed to come at room temperature over 10 min and stirred for another 10 min. The solution was cooled TO-78 °C. A solution OF PYRIDINE-4-YL-CARBAMIC acid-tert-butyl ester (117) (22 g, 113.26 mmol) in THF was added slowly. The solution was allowed to come at room temperature within 3 h. After stirring at room temperature for 15 min the solution was again cooled to -78 OC and a freshly crushed dry ice was added. The solution was allowed to come at room temperature, stirred for 30 min and poured into ice cold 10 percent NH4C1 solution. The solution was basified by IN NaOH solution and washed by dichloromethane. The pH of aqueous phase was adjusted to 4 by cold 10 percent HC1 solution. The solids formed were filtered, washed by water and dried under vacuum at room temperature to yield 16.3 g (30 percent) 4-tert-butoxycarbonylamino-nicotinic acid (118) as white solids. MP: 260 °C ; 1H- NMR (DMSO-d6): d 1.49 (s, 9H), 8.23 (d, J= 6.0 Hz, 1H), 8.55 (D, J= 6.0 Hz, 1H), 8. 96 (s, 1H); EIMS M/Z 238 (M+1).
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 16, p. 3023 - 3025
[2] Patent: WO2014/117090, 2014, A1, . Location in patent: Page/Page column 123-124
[3] Patent: WO2005/21546, 2005, A1, . Location in patent: Page/Page column 124; 207-208
  • 17
  • [ 109-72-8 ]
  • [ 98400-69-2 ]
  • [ 171178-34-0 ]
Reference: [1] Patent: US5654307, 1997, A,
  • 18
  • [ 594-19-4 ]
  • [ 98400-69-2 ]
  • [ 171178-34-0 ]
YieldReaction ConditionsOperation in experiment
64% With carbon dioxide In tetrahydrofuran; pentane B.
4-(Boc-amino)pyridine-3-carboxylic Acid.
To a stirring solution of 4-(Boc-amino)pyridine (1.027 g, 5.30 mmol) in THF at -36 °C (internal temperature) was added a 1.7 M solution of t-butyl lithium in pentane(6.5 mL, 11 mmol), and the rate of addition was controlled so as to keep the internal temperature below -28 °C.
After an additional hour (temperature kept between -30 °C and -50 °C) carbon dioxide (g) was bubbled through the solution and the cold bath was removed.
After about 15 min, the mixture was poured into ice water and the aqueous phase was washed with dichloromethane.
The pH was adjusted to 4-5 with citric acid and the resulting precipitate was washed with dichloromethane and methanol and dried in vacuo to give 0.811 g (64percent) of an off-white solid.
1H-NMR
IS-MS, m/e 239.0 (m+1)
Reference: [1] Patent: EP1140905, 2003, B1,
  • 19
  • [ 98400-69-2 ]
  • [ 257937-08-9 ]
YieldReaction ConditionsOperation in experiment
52%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃;
Stage #2: With carbon tetrabromide In tetrahydrofuran
tert-Butyl (3-bromopyridin-4-yl)carbamate (3f) (52percent) was prepared from pyridine 2f (2.70 g, 13.9 mmol) [34]. White solid; mp 91-92 °C. 1H NMR (400 MHz, CDCl3) δ 8.58 (s, 1H), 8.37 (d, J=5.6 Hz, 1H), 8.15 (d, J=5.6 Hz, 1H), 7.18 (s, 1H), 1.55 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 151.6, 151.4, 149.4, 143.1, 113.1, 109.6, 82.4, 28.1 (3C).
Reference: [1] Journal of Organic Chemistry, 1999, vol. 64, # 26, p. 9430 - 9443
[2] European Journal of Medicinal Chemistry, 2015, vol. 102, p. 403 - 412
  • 20
  • [ 98400-69-2 ]
  • [ 259809-24-0 ]
Reference: [1] Heterocycles, 2004, vol. 63, # 7, p. 1555 - 1561
  • 21
  • [ 98400-69-2 ]
  • [ 365996-04-9 ]
Reference: [1] Heterocycles, 2004, vol. 63, # 7, p. 1555 - 1561
[2] Patent: EP1577301, 2005, A1, . Location in patent: Page/Page column 70
[3] Patent: EP1405852, 2004, A1, . Location in patent: Page 63
[4] Patent: EP1577302, 2005, A1, . Location in patent: Page/Page column 67
  • 22
  • [ 7783-06-4 ]
  • [ 98400-69-2 ]
  • [ 365996-04-9 ]
Reference: [1] Patent: EP1270557, 2003, A1,
[2] Patent: US2005/20645, 2005, A1,
  • 23
  • [ 98400-69-2 ]
  • [ 1101120-47-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 1, p. 69 - 85
  • 24
  • [ 98400-69-2 ]
  • [ 1060812-84-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 1, p. 69 - 85
  • 25
  • [ 98400-69-2 ]
  • [ 1101120-37-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 1, p. 69 - 85
  • 26
  • [ 98400-69-2 ]
  • [ 885276-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 1, p. 69 - 85
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 98400-69-2 ]

Edoxaban Related Intermediates

Chemical Structure| 143150-92-9

[ 143150-92-9 ]

2-Bromo-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine

Chemical Structure| 1779-49-3

[ 1779-49-3 ]

Methyltriphenylphosphonium bromide

Chemical Structure| 273-70-1

[ 273-70-1 ]

Thiazolo[5,4-c]pyridine

Chemical Structure| 365996-05-0

[ 365996-05-0 ]

tert-Butyl 2-amino-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate

Chemical Structure| 79099-07-3

[ 79099-07-3 ]

1-Boc-4-Piperidone

Related Functional Groups of
[ 98400-69-2 ]

Amides

Chemical Structure| 56700-70-0

[ 56700-70-0 ]

tert-Butyl pyridin-3-ylcarbamate

Similarity: 0.91

Chemical Structure| 433711-95-6

[ 433711-95-6 ]

tert-Butyl (2-bromopyridin-4-yl)carbamate

Similarity: 0.87

Chemical Structure| 116026-93-8

[ 116026-93-8 ]

tert-Butyl (3-formylpyridin-4-yl)carbamate

Similarity: 0.86

Chemical Structure| 234108-73-7

[ 234108-73-7 ]

tert-Butyl 2-chloropyridine-4-carbamate

Similarity: 0.85

Chemical Structure| 262295-94-3

[ 262295-94-3 ]

tert-Butyl (2-cyanopyridin-4-yl)carbamate

Similarity: 0.85

Amines

Chemical Structure| 56700-70-0

[ 56700-70-0 ]

tert-Butyl pyridin-3-ylcarbamate

Similarity: 0.91

Chemical Structure| 433711-95-6

[ 433711-95-6 ]

tert-Butyl (2-bromopyridin-4-yl)carbamate

Similarity: 0.87

Chemical Structure| 116026-93-8

[ 116026-93-8 ]

tert-Butyl (3-formylpyridin-4-yl)carbamate

Similarity: 0.86

Chemical Structure| 234108-73-7

[ 234108-73-7 ]

tert-Butyl 2-chloropyridine-4-carbamate

Similarity: 0.85

Chemical Structure| 262295-94-3

[ 262295-94-3 ]

tert-Butyl (2-cyanopyridin-4-yl)carbamate

Similarity: 0.85

Related Parent Nucleus of
[ 98400-69-2 ]

Pyridines

Chemical Structure| 56700-70-0

[ 56700-70-0 ]

tert-Butyl pyridin-3-ylcarbamate

Similarity: 0.91

Chemical Structure| 433711-95-6

[ 433711-95-6 ]

tert-Butyl (2-bromopyridin-4-yl)carbamate

Similarity: 0.87

Chemical Structure| 116026-93-8

[ 116026-93-8 ]

tert-Butyl (3-formylpyridin-4-yl)carbamate

Similarity: 0.86

Chemical Structure| 234108-73-7

[ 234108-73-7 ]

tert-Butyl 2-chloropyridine-4-carbamate

Similarity: 0.85

Chemical Structure| 262295-94-3

[ 262295-94-3 ]

tert-Butyl (2-cyanopyridin-4-yl)carbamate

Similarity: 0.85